Zai Lab Announces Participation in January Investor Conference
December 19 2023 - 6:30AM
Business Wire
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conference in January 2024:
J.P. Morgan 42nd Annual Healthcare
Conference Presentation: Monday, January 8, 2024, 3:45 p.m. PST
Location: San Francisco
A live webcast of the presentation will be available on the
Investor Relations page of Zai Lab’s website at
ir.zailaboratory.com/webcasts-presentations and archived replay
will be available for up to 90 days following the completion of the
event.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious diseases, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219157820/en/
Investor Relations: Christine Chiou / Lina Zhang +1 (917)
886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen +1 (415) 317-7255 /
+86 185 0015 5011 shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From May 2024 to Jun 2024
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Jun 2023 to Jun 2024